一个基于Drosophila的新型药物重定位平台确定了Fingolimod作为TDP-43蛋白质病变的潜在治疗药物

相关实验视频

Updated: Oct 2, 2026

Purification of Transcripts and Metabolites from Drosophila Heads

Purification of Transcripts and Metabolites from Drosophila Heads

Published on: March 15, 2013

Luca Lo Piccolo^1,2, Takanari Umegawachi³, Ranchana Yeewa¹

¹Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

|July 26, 2023

概括

芬戈利莫德显示了与TARDNA结合蛋白43 (TDP-43) 病理学相关的神经退行性疾病的治疗潜力. 这项研究确定fingolimod是减少TDP-43毒性和改善疾病模型中的运动功能的有希望的候选药物.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

在TARDNA结合蛋白43 (TDP-43) 中的致病性改变与进展性神经退行性疾病有关.
目前对TDP-43蛋白病变缺乏治疗方法,因此需要新的治疗策略.

研究的目的:

确定与TDP-43病理相关的神经退行性疾病的潜在治疗方法.
评估药物重定向对TDP-43相关疾病的疗效.

主要方法:

开发表达野生类型或突变TDP-43 (G384C) 的Drosophila melanogaster模型.
实施三阶段药物查策略,重点关注化率和机车功能.
评估fingolimod对TDP-43水平,幼死亡率和运动缺陷的影响.

主要成果:

芬戈利莫德在野生类型和突变的TDP-43 Drosophila模型中都表现出有益作用.
该药物在转录后降低了TDP-43水平,并挽救了幼的死亡率.
芬戈利莫德在研究模型中显著改善了运动器官功能障碍.

结论:

芬戈利莫德是改善TDP-43毒性和相关神经退行性病理的有希望的治疗候选药物.
开发的Drosophila查平台有效地识别了TDP-43相关疾病的新疗法.
需要对TDP-43蛋白病变进行进一步的调查和临床试验.

关键词:

骨髓缩侧面硬化症 (ALS) 是一种草 (Drosophila Melanogaster) 是一种有机植物.药物重用药物重用在Fingolimod中使用.在前性痴呆症.在TDP-43中使用.

更多相关视频

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy

Published on: August 3, 2021

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...